EM2AI Revolutionising the Dental Industry: New AI Products Promise Transparent Treatment Plans for Patients
2024年4月23日 - 3:00PM
JCN Newswire
EM2AI Pte. Ltd., ("EM2AI" or the "Company") an Artificial
Intelligence (AI) dental healthcare company based in Singapore
today announced a groundbreaking development poised to reshape the
landscape of dental care, with the launch of its pioneering dental
AI product. Scheduled to go live later this year, this innovative
tool aims to provide dentists and patients with unparalleled
transparency and accuracy in treatment planning, marking a
significant leap forward for the dental industry.
Mr Ryan San, Chief Executive Officer of EM2AI expressed profound
enthusiasm about the forthcoming launch, stating, "Our new dental
AI product represents a culmination of years of rigorous research
and development, supported by key government agencies such as AI
Singapore that have been tasked to promulgate the usage of AI in
Singapore. With this revolutionary technology, we are empowering
both dentists and patients with the ability to access transparent
treatment plans devoid of bias or preference, ensuring full
disclosure and transparency in every aspect of dental care."
Powered by cutting-edge generative AI algorithms, this
groundbreaking solution analyses a comprehensive array of
patient-specific data, including medical, dental, and social
history, demographics, concerns, and investigations. By leveraging
this wealth of information, EM2AI is pioneering a transformative
approach to formulate optimal dental treatment plans, heralding a
new era of precision and integrity in dental healthcare.
EM2AI has developed and successfully deployed the Artificial
Intelligence X-Ray Dental Condition Detection and Automated Dental
Charting (ADC) systems in all Q & M Dental clinics in
Singapore. These are integrated into the Q & M app that is now
available to the public for download.
EM2AI is now in the early stages of rolling out the Generative AI
Treatment Plan (GATP) in selected outlets for testing with the view
for a full rollout in due course. This ground-breaking AI-driven
system is designed to support dentists by enhancing the speed and
accuracy of diagnosing and creating treatment plans for their
patients. The core advantage of GATP lies in its ability to
minimise and remove perceived or unperceived biases or preferences
that a dentist might hold, thus improving the transparency,
reliability, consistency, and quality of dental diagnoses and
treatments.
"EM2AI's integration of AI in dentistry addresses patients' concern
about excessive or insufficient treatment recommendations,
fostering an ethical dental approach that patients are actively
pursuing. AI Singapore is committed to driving Singapore's journey
as an AI-first nation. We want to continue supporting our local
enterprises as they innovate with AI integration in their
offerings, striving to elevate consumer experiences and make a
positive impact on society," said Mr Laurence Liew, Director of AI
Innovation, AI Singapore.
Furthermore, EM2AI's model represents a new business paradigm
within the dental industry through its Software as a Service (SaaS)
offering. The SaaS platform ensures that dental clinics, regardless
of their size, can offer state-of-the-art and personalised
treatment plans to their patients, fostering a more inclusive and
advanced dental care ecosystem. Through continuous updates and
improvements, EM2AI's system promises to evolve alongside
advancements in AI and dental medicine, ensuring that dentists are
always equipped with the most effective tools to serve their
patients.
With this launch, the Company also plans to seek investors and
strategic partners, both locally and overseas, for the next phase
of the Companys growth plans.
About EM2AI
EM2AI Pte. Ltd. ("EM2AI") is a 49%-owned company of Q & M
Dental Group (Singapore) Limited (QC7.SI) focusing on developing
AI-powered solutions, including a cloud-based Integrated Dental
Management System ("EM2Clinic") that facilitates patients and
clinic management in an efficient way.
For more information, please contact: Waterbrooks Consultants Pte
Ltd
Wayne Koo - wayne.koo@waterbrooks.com.sg +65 9338-8166
Derek Yeo - derek@waterbrooks.com.sg +65 9791-4707
Proud Investor Relations partner: https://www.waterbrooks.com.sg/
and https://www.shareinvestorholdings.com/
Source: EM2AI Pte. Ltd
Copyright 2024 JCN Newswire . All rights reserved.